Frail clinical trials

Explore recruiting frail clinical trials.

Recruiting frail studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Frail trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PirtobrUtinib as frontline Therapy for elderly unfit/frail patient with MAntle cell lymphoma: a phase II study of the Fondazione Italiana Linfomi (FIL)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

CLL-Frail - A prospective, multicenter phase II trial of acalabrutinib in very old (≥80y) or frail CLL-Patients

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter, phase II, national and open-label study to evaluate Iberdomide-dexamethasone alone or in combination with standard MM treatment regimens in transplant ineligible newly diagnosed patients.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase IV, open-label, randomized clinical trial on the effect of intravenous iron on quality of life in elderly patients with Acute Coronary Syndrome.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients: Insights from the DOAC-FRAIL RCT. A step towards safe(r) DOAC utilization in the frail older population.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Frail trials by city

Frail in Toronto Frail in Vancouver Frail in Montreal Frail in Calgary Frail in Edmonton Frail in Ottawa Frail in Winnipeg Frail in Quebec City Frail in Hamilton Frail in Kitchener Frail in London Frail in Halifax Frail in New York Frail in Los Angeles Frail in Chicago Frail in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease